- Home
- LIQT vs NXL Comparison
LIQT vs NXL Comparison
Compare LIQT & NXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LIQT | NXL |
|---|---|---|
| Founded | 2004 | 2010 |
| Country | Denmark | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.9M | 18.6M |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | LIQT | NXL |
|---|---|---|
| Price | $1.62 | $0.48 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $4.20 | ★ $5.00 |
| AVG Volume (30 Days) | 6.5K | ★ 474.4K |
| Earning Date | 03-27-2026 | 03-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $16,788,295.00 | $156,931.00 |
| Revenue This Year | $29.90 | $38.28 |
| Revenue Next Year | $17.74 | $185.71 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 10.97 | N/A |
| 52 Week Low | $1.34 | $0.50 |
| 52 Week High | $3.35 | $3.73 |
Technical Indicators
Market Signals| Indicator | LIQT | NXL |
|---|---|---|
| Relative Strength Index (RSI) | 42.13 | 31.09 |
| Support Level | $1.50 | $0.50 |
| Resistance Level | $1.76 | $0.55 |
| Average True Range (ATR) | 0.12 | 0.05 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 17.78 | 6.43 |
Price Performance
Historical ComparisonAbout LIQT LiqTech International Inc.
LiqTech International Inc is a clean technology company which provides technology for gas and liquid purification by manufacturing ceramic silicon carbide filters. The company is engaged in businesses that are liquid filtration market and the silicon carbide ceramic membrane & diesel particulate filter (DPF) market. The company's product portfolio consists of ceramic silicon membranes for liquid filtration, diesel particulate filters, and others. Its operating segment includes Water, Ceramics, and Plastics.
About NXL Nexalin Technology Inc.
Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.